Genentech, Roche Settle With PDL BioPharma Over Licensing

Law360, Washington (February 4, 2014, 6:42 PM EST) -- Biotechnology giant Genentech Inc. and its parent, F. Hoffmann-La Roche Ltd., have reached an agreement with patent licensing company PDL Biopharma Inc. over pharmaceutical royalties, ending Nevada state court litigation and a New Jersey arbitration dispute, PDL announced Monday.

Under the terms of the deal, Genentech will enter into a licensing agreement with PDL in exchange for the resolution of all legal disputes between the companies, which includes the court and arbitration cases and a U.S. patent dispute involving macular degeneration treatment Lucentis.

Genentech will pay...
To view the full article, register now.